Literature DB >> 24770624

The acute effects of MDMA and ethanol administration on electrophysiological correlates of performance monitoring in healthy volunteers.

D B Spronk1, G J H Dumont, R J Verkes, E R A De Bruijn.   

Abstract

RATIONALE: Knowing how commonly used drugs affect performance monitoring is of great importance, because drug use is often associated with compromised behavioral control. Two of the most commonly used recreational drugs in the western world, 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and ethanol (alcohol), are also often used in combination. The error-related negativity (ERN), correct-related negativity (CRN), and N2 are electrophysiological indices of performance monitoring.
OBJECTIVES: The present study aimed to investigate how ethanol, MDMA, and their co-administration affect performance monitoring as indexed by the electrophysiological correlates.
METHODS: Behavioral and EEG data were obtained from 14 healthy volunteers during execution of a speeded choice-reaction-time task after administration of ethanol, MDMA, and combined ethanol and MDMA, in a double-blind, placebo-controlled, randomized crossover design.
RESULTS: Ethanol significantly reduced ERN amplitudes, while administration of MDMA did not affect the ERN. Co-administration of MDMA and ethanol did not further impair nor ameliorate the effect of ethanol alone. No drug effects on CRN nor N2 were observed. DISCUSSION: A decreased ERN following ethanol administration is in line with previous work and offers further support for the impairing effects of alcohol intoxication on performance monitoring. This impairment may underlie maladaptive behavior in people who are under influence. Moreover, these data demonstrate for the first time that MDMA does not affect performance monitoring nor does it interact with ethanol in this process. These findings corroborate the notion that MDMA leaves central executive functions relatively unaffected.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770624     DOI: 10.1007/s00213-014-3456-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  59 in total

Review 1.  Substance use disorders, externalizing psychopathology, and P300 event-related potential amplitude.

Authors:  William G Iacono; Stephen M Malone; Matt McGue
Journal:  Int J Psychophysiol       Date:  2003-05       Impact factor: 2.997

2.  Strategic control and medial frontal negativity: beyond errors and response conflict.

Authors:  Bruce D Bartholow; Melanie A Pearson; Cheryl L Dickter; Kenneth J Sher; Monica Fabiani; Gabriele Gratton
Journal:  Psychophysiology       Date:  2005-01       Impact factor: 4.016

3.  P300 amplitude as an indicator of externalizing in adolescent males.

Authors:  Christopher J Patrick; Edward M Bernat; Stephen M Malone; William G Iacono; Robert F Krueger; Matt McGue
Journal:  Psychophysiology       Date:  2006-01       Impact factor: 4.016

4.  N2, P3 and the lateralized readiness potential in a nogo task involving selective response priming.

Authors:  B Kopp; U Mattler; R Goertz; F Rist
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1996-07

5.  MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.

Authors:  K P C Kuypers; N Samyn; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2006-07-08       Impact factor: 4.530

6.  The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.

Authors:  Con Stough; Rebecca King; Katherine Papafotiou; Phillip Swann; Edward Ogden; Keith Wesnes; Luke A Downey
Journal:  Psychopharmacology (Berl)       Date:  2011-10-22       Impact factor: 4.530

7.  Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology.

Authors:  G J H Dumont; C Kramers; F C G J Sweep; J J Willemsen; D J Touw; R C Schoemaker; J M A van Gerven; J K Buitelaar; R J Verkes
Journal:  J Psychopharmacol       Date:  2008-12-12       Impact factor: 4.153

8.  Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

Authors:  Li-Tzy Wu; William E Schlenger; Deborah M Galvin
Journal:  Drug Alcohol Depend       Date:  2006-02-17       Impact factor: 4.492

9.  Allelic variation of serotonin transporter function modulates the brain electrical response for error processing.

Authors:  Andreas J Fallgatter; Martin J Herrmann; Josefine Roemmler; Ann-Christine Ehlis; Annika Wagener; Anke Heidrich; Gabriele Ortega; Yong Zeng; Klaus-Peter Lesch
Journal:  Neuropsychopharmacology       Date:  2004-08       Impact factor: 7.853

10.  When errors are rewarding.

Authors:  Ellen R A de Bruijn; Floris P de Lange; D Yves von Cramon; Markus Ullsperger
Journal:  J Neurosci       Date:  2009-09-30       Impact factor: 6.167

View more
  4 in total

Review 1.  MDMA for the treatment of mood disorder: all talk no substance?

Authors:  Rachel Patel; Daniel Titheradge
Journal:  Ther Adv Psychopharmacol       Date:  2015-06

2.  Alcohol and Neural Dynamics: A Meta-analysis of Acute Alcohol Effects on Event-Related Brain Potentials.

Authors:  Catharine E Fairbairn; Dahyeon Kang; Kara D Federmeier
Journal:  Biol Psychiatry       Date:  2020-12-11       Impact factor: 13.382

3.  Electrophysiological correlates of oxytocin-induced enhancement of social performance monitoring.

Authors:  Ellen R A de Bruijn; Margit I Ruissen; Sina Radke
Journal:  Soc Cogn Affect Neurosci       Date:  2017-10-01       Impact factor: 3.436

4.  Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats.

Authors:  Ibrahim M Shokry; Connor J Shields; John J Callanan; Zhiyuan Ma; Rui Tao
Journal:  BMC Pharmacol Toxicol       Date:  2019-08-05       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.